$ABT ABBOTT LABORATORIES Insider Trading Week 35/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ABBOTT LABORATORIES in week 35/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 44.40 | 39,953 | 1,773,913 | 0 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 20,133 | 773,107 | 0 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 47.00 | 12,012 | 564,564 | 45,709 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Payment of Exercise | F | 109.47 | 47,772 | 5,229,601 | 89,003 | 136.8 K to 89 K (-34.93 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 44.40 | 39,953 | 1,773,913 | 136,775 | 96.8 K to 136.8 K (+41.26 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 20,133 | 773,107 | 96,822 | 76.7 K to 96.8 K (+26.25 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 47.00 | 12,012 | 564,564 | 76,689 | 64.7 K to 76.7 K (+18.57 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 108.73 | 6,290 | 683,929 | 56,630 | 62.9 K to 56.6 K (-10.00 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 27.03 | 52,300 | 1,413,857 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 111.86 | 52,300 | 5,850,278 | 316,800 | 369.1 K to 316.8 K (-14.17 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 27.03 | 52,300 | 1,413,857 | 369,100 | 316.8 K to 369.1 K (+16.51 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 27.03 | 52,300 | 1,413,857 | 0 | |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 111.86 | 52,300 | 5,850,278 | 316,800 | 369.1 K to 316.8 K (-14.17 %) |
| Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 27.03 | 52,300 | 1,413,857 | 369,100 | 316.8 K to 369.1 K (+16.51 %) |